Currently holds a position at Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Co-Founder, Chief Operating Officer | Apellis Pharmaceuticals Inc | Jan. 1, 2016 - |
Chief Operating Officer | Apellis Pharmaceuticals Inc | Sept. 1, 2009 - Jan. 1, 2016 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Value | Details | |
---|---|---|---|---|---|---|---|---|
2025-01-30 | 2025-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
826
-0.1%
29.52USD 24,386 |
826 -0.1% | 29.52 | USD 24,386 | |
2024-05-09 | 2024-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
100
-0.0%
44.03USD 4,403 |
100 -0.0% | 44.03 | USD 4,403 | |
2024-05-09 | 2024-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
22,472
-2.0%
42.85USD 962,903 |
22,472 -2.0% | 42.85 | USD 962,903 | |
2024-05-09 | 2024-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
56,335
-4.7%
42.15USD 2,374,543 |
56,335 -4.7% | 42.15 | USD 2,374,543 | |
2024-04-09 | 2024-04-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
4,728
-0.4%
54.92USD 259,639 |
4,728 -0.4% | 54.92 | USD 259,639 | |
2024-04-09 | 2024-04-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
64,379
-5.4%
54.12USD 3,483,966 |
64,379 -5.4% | 54.12 | USD 3,483,966 | |
2024-03-11 | 2024-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
100
-0.0%
63.35USD 6,335 |
100 -0.0% | 63.35 | USD 6,335 | |
2024-03-11 | 2024-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
26,257
-2.3%
62.69USD 1,646,041 |
26,257 -2.3% | 62.69 | USD 1,646,041 | |
2024-03-11 | 2024-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
42,750
-3.6%
61.88USD 2,645,173 |
42,750 -3.6% | 61.88 | USD 2,645,173 | |
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
1,148
-0.1%
67.77USD 77,796 |
1,148 -0.1% | 67.77 | USD 77,796 | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
874
-0.1%
64.14USD 56,057 |
874 -0.1% | 64.14 | USD 56,057 | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
3,913
-0.3%
65.00USD 254,329 |
3,913 -0.3% | 65.00 | USD 254,329 | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
1,632
-0.1%
66.81USD 109,032 |
1,632 -0.1% | 66.81 | USD 109,032 | |
2023-11-09 | 2023-11-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.1%
47.27USD 567,240 |
12,000 -1.1% | 47.27 | USD 567,240 | |
2023-10-10 | 2023-10-09 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.1%
40.38USD 484,560 |
12,000 -1.1% | 40.38 | USD 484,560 | |
2023-09-11 | 2023-09-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
12,000
-1.1%
42.87USD 514,440 |
12,000 -1.1% | 42.87 | USD 514,440 | |
2023-08-09 | 2023-08-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.1%
23.66USD 283,920 |
12,000 -1.1% | 23.66 | USD 283,920 | |
2023-07-11 | 2023-07-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.1%
84.55USD 1,014,600 |
12,000 -1.1% | 84.55 | USD 1,014,600 | |
2023-06-09 | 2023-06-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.1%
91.35USD 1,096,200 |
12,000 -1.1% | 91.35 | USD 1,096,200 | |
2023-05-09 | 2023-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.1%
92.39USD 1,108,680 |
12,000 -1.1% | 92.39 | USD 1,108,680 | |
2023-04-11 | 2023-04-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
78.21USD 938,520 |
12,000 -1.2% | 78.21 | USD 938,520 | |
2023-03-10 | 2023-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
63.79USD 765,480 |
12,000 -1.2% | 63.79 | USD 765,480 | |
2023-02-10 | 2023-02-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
54.45USD 653,400 |
12,000 -1.2% | 54.45 | USD 653,400 | |
2023-01-10 | 2023-01-09 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
46.08USD 552,960 |
12,000 -1.2% | 46.08 | USD 552,960 | |
2022-12-12 | 2022-12-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
47.50USD 570,000 |
12,000 -1.2% | 47.50 | USD 570,000 | |
2022-11-10 | 2022-11-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
46.47USD 557,640 |
12,000 -1.2% | 46.47 | USD 557,640 | |
2022-10-11 | 2022-10-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
57.50USD 690,000 |
12,000 -1.2% | 57.50 | USD 690,000 | |
2022-09-12 | 2022-09-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.2%
63.98USD 767,760 |
12,000 -1.2% | 63.98 | USD 767,760 | |
2022-08-09 | 2022-08-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.3%
62.50USD 750,000 |
12,000 -1.3% | 62.50 | USD 750,000 | |
2022-07-12 | 2022-07-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.3%
47.95USD 575,400 |
12,000 -1.3% | 47.95 | USD 575,400 | |
2022-06-09 | 2022-06-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,000
-1.3%
44.09USD 529,080 |
12,000 -1.3% | 44.09 | USD 529,080 | |
2022-05-02 | 2022-04-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
4,000
-0.4%
44.43USD 177,720 |
4,000 -0.4% | 44.43 | USD 177,720 | |
2021-06-25 | 2021-06-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
6,250
-0.7%
65.61USD 410,063 |
6,250 -0.7% | 65.61 | USD 410,063 | |
2021-05-25 | 2021-05-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
6,250
-0.7%
47.40USD 296,250 |
6,250 -0.7% | 47.40 | USD 296,250 | |
2021-04-26 | 2021-04-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
6,250
-0.7%
46.13USD 288,313 |
6,250 -0.7% | 46.13 | USD 288,313 | |
2021-03-11 | 2021-03-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
6,250
-0.7%
50.74USD 317,125 |
6,250 -0.7% | 50.74 | USD 317,125 | |
2020-02-14 | 2020-02-13 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
55,398
-5.2%
40.98USD 2,270,155 |
55,398 -5.2% | 40.98 | USD 2,270,155 | |
2020-02-14 | 2020-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
52,075
-5.2%
42.80USD 2,228,966 |
52,075 -5.2% | 42.80 | USD 2,228,966 | |
2019-09-26 | 2019-09-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,010
-0.1%
25.64USD 25,897 |
1,010 -0.1% | 25.64 | USD 25,897 | |
2019-09-26 | 2019-09-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
20,531
-2.3%
25.24USD 518,161 |
20,531 -2.3% | 25.24 | USD 518,161 | |
2019-09-25 | 2019-09-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,295
-0.1%
24.96USD 32,321 |
1,295 -0.1% | 24.96 | USD 32,321 | |
2019-09-25 | 2019-09-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
20,307
-2.2%
24.56USD 498,760 |
20,307 -2.2% | 24.56 | USD 498,760 | |
2019-09-25 | 2019-09-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
100
-0.0%
25.53USD 2,553 |
100 -0.0% | 25.53 | USD 2,553 | |
2019-09-25 | 2019-09-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
20,758
-2.2%
25.07USD 520,362 |
20,758 -2.2% | 25.07 | USD 520,362 |
// ... existing code ... // ... rest of the file ...